Peter Howard Rheinstein | |
|---|---|
 Rheinstein in 1995 | |
| Born | September 7, 1943 |
| Nationality | American |
| Education | Michigan State University (BA, MS) Johns Hopkins University (MD) University of Maryland School of Law (JD) |
| Occupation(s) | healthcare company executive, physician, lawyer |
| Known for | regulation of prescription drug promotion |
| Spouse |
Miriam Rheinstein (m. 1969) |
| Children | Jason Rheinstein |
| Awards | Commendable Service award, Food and Drug Administration, 1981, Group award of merit, 1983, 1988, Group Commendable Service award, 1989, 1992—93, 1995, 1999, Commr.'s Special citation, 1993, American College of Legal Medicine Gold Medal (2003)[1] |
Peter Howard Rheinstein (born September 7, 1943) is an American physician, lawyer, author, and administrator (both private and governmental). He was an official of the Food and Drug Administration (FDA) 1974-1999.
Rheinstein, a General Motors Scholar, received a B.A. with high honors from Michigan State University in 1963, an M.S. in mathematics from Michigan State University in 1964, an M.D. from Johns Hopkins University in 1967, and a J.D. from the University of Maryland School of Law in 1973. At Michigan State University Rheinstein was noted for his facility in mathematics.[2][3]
Rheinstein was director of the Drug Advertising and Labeling Division, Food and Drug Administration, Rockville, 1974-1982;[4][5] he was acting deputy director Office of Drugs, 1982–83, acting director Office of Drugs; 1983–84, director Office of Drug Standards, 1984–90,[6][7] director medicine staff Office Health Affairs, 1990-99.[8][9] While at FDA Rheinstein developed precedents for Food and Drug Administration regulation of prescription drug promotion, initiated FDA’s first patient medication information program; implemented the Drug Price Competition and Patent Term Restoration Act of 1984, and authored medication goals for Healthy People 2000 and 2010.[10][11][12][13][14][15] Judy Woodruff interviewed Rheinstein about generic drug safety on the McNeil-Lehrer NewsHour, 11 Dec 1985.[16] Stone Phillips interviewed Rheinstein about drug labeling on Dateline NBC, March 31, 1992.[17]
From 1999 – 2004, Rheinstein was senior vice president for medical and clinical affairs, Cell Works, Inc., Baltimore. Among other projects, Cell Works wanted to develop a blood test for anthrax, similar to a system for cancer cells it produced. "It's something that companies like ours can incorporate into our diagnostic technology," Rheinstein told the Washington Times. Biodefense projects "create new technologies, the spin-offs of which can be commercialized into some pretty good things."[18] In 2000 Rheinstein became president of Severn Health Solutions in Severna Park, Maryland. In 2010 Rheinstein was named president of the Academy of Physicians in Clinical Research [19] and in 2011 was named chairman of the American Board of Legal Medicine. Rheinstein was named chairman of the United States Adopted Names Council in 2012. Rheinstein is a member of Phi Kappa Phi,[20] and vice-president of the Intercultural Friends Foundation.[21] Rheinstein is publisher of Discovery Medicine and chairman of MedData Foundation.[22] He is president-elect of the Academy of Medicine of Washington, DC.[23] Sarah Gonzalez interviewed Rheinstein for Planet Money, This is Your Brain on Drug Ads, 8 Sept 2021.[24]
